Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 02:41PM ET
46.92
Dollar change
+0.10
Percentage change
0.22
%
Index- P/E- EPS (ttm)-8.33 Insider Own6.45% Shs Outstand82.32M Perf Week0.59%
Market Cap3.86B Forward P/E- EPS next Y-5.16 Insider Trans-3.40% Shs Float77.02M Perf Month-11.04%
Income-606.64M PEG- EPS next Q-1.76 Inst Own104.73% Short Float4.91% Perf Quarter-4.60%
Sales434.25M P/S8.90 EPS this Y21.81% Inst Trans-3.16% Short Ratio4.93 Perf Half Y27.13%
Book/sh3.35 P/B14.02 EPS next Y20.09% ROA-39.80% Short Interest3.78M Perf Year24.60%
Cash/sh7.03 P/C6.67 EPS next 5Y8.90% ROE-193.23% 52W Range31.52 - 54.98 Perf YTD-1.87%
Dividend Est.- P/FCF- EPS past 5Y-15.75% ROI-51.92% 52W High-14.65% Beta0.65
Dividend TTM- Quick Ratio2.49 Sales past 5Y63.06% Gross Margin88.54% 52W Low48.87% ATR (14)1.60
Dividend Ex-Date- Current Ratio2.61 EPS Y/Y TTM17.65% Oper. Margin-131.08% RSI (14)46.79 Volatility3.04% 3.47%
Employees1276 Debt/Eq3.39 Sales Y/Y TTM19.52% Profit Margin-139.70% Recom1.32 Target Price88.16
Option/ShortYes / Yes LT Debt/Eq3.24 EPS Q/Q29.83% Payout- Rel Volume0.22 Prev Close46.82
Sales Surprise6.71% EPS Surprise10.98% Sales Q/Q23.27% EarningsFeb 15 AMC Avg Volume766.77K Price46.92
SMA20-3.48% SMA50-0.53% SMA20010.91% Trades Volume137,496 Change0.22%
Date Action Analyst Rating Change Price Target Change
Dec-08-23Initiated Wells Fargo Overweight $72
Jun-14-23Resumed Credit Suisse Outperform $96
Jun-06-23Upgrade Evercore ISI In-line → Outperform $60 → $80
Apr-26-23Initiated Cantor Fitzgerald Overweight $114
Jan-18-23Resumed Canaccord Genuity Buy $90
Dec-30-22Resumed H.C. Wainwright Buy $82
Nov-03-22Upgrade Robert W. Baird Neutral → Outperform $50
Oct-13-22Upgrade Guggenheim Neutral → Buy $50
Aug-01-22Downgrade Evercore ISI Outperform → In-line $95 → $60
Mar-16-22Upgrade Credit Suisse Neutral → Outperform $99 → $105
Mar-22-24 04:00PM
Mar-20-24 08:11AM
Mar-12-24 05:00PM
Mar-11-24 03:00PM
Mar-08-24 09:38AM
04:30PM Loading…
Feb-27-24 04:30PM
Feb-23-24 04:05PM
Feb-16-24 10:43AM
10:35AM
07:53AM
Feb-15-24 04:15PM
04:01PM
Feb-13-24 01:36PM
Feb-08-24 04:00PM
Feb-06-24 08:00AM
04:05PM Loading…
Feb-05-24 04:05PM
Jan-25-24 04:05PM
Jan-19-24 04:00PM
Jan-18-24 02:41PM
Jan-09-24 06:20PM
Jan-08-24 12:18PM
07:00AM
Jan-07-24 11:00AM
Jan-04-24 08:12AM
08:00AM
Jan-03-24 08:00AM
Jan-02-24 04:05PM
Dec-27-23 06:41PM
Dec-21-23 05:21PM
04:30PM
09:29AM Loading…
Dec-18-23 09:29AM
08:00AM
Dec-15-23 10:18AM
Nov-20-23 04:30PM
Nov-17-23 04:30PM
Nov-07-23 05:00PM
Nov-04-23 01:12PM
12:16PM
Nov-03-23 11:43AM
Nov-02-23 06:26PM
04:36PM
04:05PM
Oct-26-23 04:05PM
Oct-25-23 06:17AM
Oct-23-23 04:01PM
04:01PM
Oct-20-23 04:00PM
Oct-18-23 09:16PM
Oct-17-23 04:02PM
Oct-16-23 08:00AM
Oct-14-23 04:30PM
Oct-12-23 05:00PM
Oct-09-23 08:00AM
Oct-05-23 08:00AM
Sep-25-23 05:13PM
Sep-20-23 05:00PM
Sep-07-23 12:36PM
Aug-31-23 09:00AM
Aug-18-23 05:00PM
Aug-12-23 11:05AM
Aug-11-23 11:14AM
Aug-10-23 06:27PM
Aug-08-23 07:11AM
06:20AM
Aug-04-23 08:34AM
08:12AM
Aug-03-23 04:09PM
04:00PM
Jul-31-23 08:00AM
Jul-27-23 05:00PM
05:05AM
Jul-18-23 05:00PM
Jul-13-23 03:00PM
Jul-12-23 08:00AM
Jul-07-23 07:46AM
Jul-06-23 08:00AM
Jun-28-23 11:06AM
Jun-21-23 08:00AM
Jun-20-23 05:00PM
Jun-09-23 10:55AM
Jun-07-23 05:00PM
03:21AM
Jun-05-23 04:00PM
May-24-23 06:39AM
May-19-23 08:30AM
May-18-23 05:00PM
11:15AM
May-17-23 08:00AM
May-15-23 02:43PM
May-08-23 04:02PM
May-05-23 04:01PM
10:24AM
08:27AM
May-04-23 04:01PM
Apr-28-23 12:27PM
Apr-27-23 04:05PM
Apr-19-23 04:01PM
Apr-18-23 03:27PM
Mar-28-23 04:01PM
Mar-21-23 08:30AM
Ultragenyx Pharmaceutical, Inc. engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010, and is headquartered in Novato, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kassberg Thomas RichardCBO & EVPMar 11 '24Sale49.9311,509574,644252,823Mar 12 01:41 PM
Fust Matthew KDirectorMar 07 '24Sale50.8812,195620,44314,860Mar 11 12:54 PM
Harris ErikEVP & Chief Commercial OfficerMar 01 '24Sale53.764,768256,32867,163Mar 05 08:08 PM
Pinion John RichardSee RemarksMar 01 '24Sale53.764,173224,34089,268Mar 05 08:15 PM
Parschauer Karah HerdmanEVP and Chief Legal OfficerMar 01 '24Sale53.763,756201,92367,340Mar 05 08:22 PM
Crombez EricEVP and Chief Medical OfficerMar 01 '24Sale53.761,23866,55548,927Mar 05 08:10 PM
Kassberg Thomas RichardCBO & EVPMar 01 '24Sale53.761,01154,351264,332Mar 05 08:19 PM
Huizenga Theodore AlanSVP, Chief Accounting OfficerMar 01 '24Sale53.7634118,33241,380Mar 05 08:13 PM
KAKKIS EMIL DPresident & CEOFeb 07 '24Sale45.0030,0001,350,000539,770Feb 08 03:49 PM
Huizenga Theodore AlanSVP, Chief Accounting OfficerJan 02 '24Option Exercise21.003,00063,00027,892Jan 02 04:06 PM
KAKKIS EMIL DPresident & CEODec 29 '23Sale47.8730,0001,436,100569,770Jan 02 04:07 PM
Kassberg Thomas RichardCBO & EVPOct 23 '23Option Exercise6.8639,878273,563286,738Oct 24 05:22 PM
Kassberg Thomas RichardCBO & EVPOct 23 '23Sale32.7839,8781,307,201246,860Oct 24 05:22 PM
KAKKIS EMIL DPresident & CEOOct 19 '23Option Exercise6.8647,853328,272647,029Oct 23 05:14 PM
KAKKIS EMIL DPresident & CEOOct 19 '23Sale33.5247,8531,604,033599,743Oct 23 05:14 PM
Huizenga Theodore AlanSVP, Chief Accounting OfficerSep 07 '23Option Exercise21.002,00042,00025,777Sep 11 01:52 PM
Huizenga Theodore AlanSVP, Chief Accounting OfficerSep 07 '23Sale40.802,16388,24923,614Sep 11 01:52 PM
Harris ErikEVP & Chief Commercial OfficerSep 05 '23Sale37.966,000227,76051,281Sep 06 05:51 PM
Huizenga Theodore AlanSVP, Chief Accounting OfficerSep 01 '23Sale37.1597036,03223,777Sep 06 05:50 PM
Sanders Corazon (Corsee) D.DirectorJun 30 '23Sale46.7658527,3558,985Jun 30 02:34 PM
Harris ErikEVP & Chief Commercial OfficerJun 19 '23Sale48.2030514,70157,281Jun 21 06:17 PM
Sanders Corazon (Corsee) D.DirectorJun 08 '23Sale51.651,48576,7009,570Jun 09 02:31 PM
Pinion John RichardSee RemarksMay 18 '23Sale50.002,012100,60074,744May 19 01:54 PM
Huizenga Theodore AlanSVP, Chief Accounting OfficerMay 09 '23Option Exercise21.003,00063,00030,747May 10 08:09 PM
Parschauer Karah HerdmanEVP and Chief Legal OfficerMay 04 '23Sale45.004,378197,01051,982May 05 02:16 PM